Correlation Between Dolby Laboratories and Aileron Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dolby Laboratories and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dolby Laboratories and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dolby Laboratories and Aileron Therapeutics, you can compare the effects of market volatilities on Dolby Laboratories and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dolby Laboratories with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dolby Laboratories and Aileron Therapeutics.

Diversification Opportunities for Dolby Laboratories and Aileron Therapeutics

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Dolby and Aileron is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Dolby Laboratories and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and Dolby Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dolby Laboratories are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of Dolby Laboratories i.e., Dolby Laboratories and Aileron Therapeutics go up and down completely randomly.

Pair Corralation between Dolby Laboratories and Aileron Therapeutics

Considering the 90-day investment horizon Dolby Laboratories is expected to generate 0.23 times more return on investment than Aileron Therapeutics. However, Dolby Laboratories is 4.33 times less risky than Aileron Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Aileron Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  7,855  in Dolby Laboratories on August 31, 2022 and sell it today you would lose (588.00)  from holding Dolby Laboratories or give up 7.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dolby Laboratories  vs.  Aileron Therapeutics

 Performance (%) 
       Timeline  
Dolby Laboratories 
Dolby Performance
0 of 100
Over the last 90 days Dolby Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Dolby Laboratories is not utilizing all of its potentials. The new stock price disturbance, may contribute to short-term losses for the investors.

Dolby Price Channel

Aileron Therapeutics 
Aileron Performance
0 of 100
Over the last 90 days Aileron Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Aileron Price Channel

Dolby Laboratories and Aileron Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dolby Laboratories and Aileron Therapeutics

The main advantage of trading using opposite Dolby Laboratories and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dolby Laboratories position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.
Dolby Laboratories vs. International Business Machines
Dolby Laboratories vs. Accenture Plc
Dolby Laboratories vs. Fiserv Inc
Dolby Laboratories vs. Cognizant Tech Sol
The idea behind Dolby Laboratories and Aileron Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Aileron Therapeutics vs. Siemens Ag ADR
Aileron Therapeutics vs. Regeneron Pharmaceuticals
Aileron Therapeutics vs. Vertex Pharmaceutic
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go